Literature Collection

Collection Insights

10K+

References

9K+

Articles

1400+

Grey Literature

4500+

Opioids & SU

The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
10858 Results
7241
Pocket Guide: Tapering Opioids for Chronic Pain
Type: Government Report
Authors: Centers for Disease Control and Prevention
Year: 2021
Publication Place: Atlanta, GA
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7243
Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability
Type: Journal Article
Authors: Travis Olives, Laurie A. Willhite, Samantha C. Lee, Danika K. Evans, Ashley Jensen, Hsiao-Ting Regelman, Eric S. McGillis
Year: 2020
Publication Place: Orange, California
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
7244
Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013
Type: Journal Article
Authors: R. M. Burns, R. L. Pacula, S. Bauhoff, A. J. Gordon, H. Hendrikson, D. L. Leslie, B. D. Stein
Year: 2016
Publication Place: United States
Abstract: BACKGROUND: State Medicaid policies play an important role in Medicaid enrollees' access to and use of opioid agonists, such as methadone and buprenorphine, in the treatment of opioid use disorders. Little information is available, however, regarding the evolution of state policies facilitating or hindering access to opioid agonists among Medicaid enrollees. METHODS: During 2013-2014, we surveyed state Medicaid officials and other designated state substance abuse treatment specialists about their state's recent history of Medicaid coverage and policies pertaining to methadone and buprenorphine. We describe the evolution of such coverage and policies and present an overview of the Medicaid policy environment with respect to opioid agonist therapy from 2004 to 2013. RESULTS: Among our sample of 45 states with information on buprenorphine and methadone coverage, we found a gradual trend toward adoption of coverage for opioid agonist therapies in state Medicaid agencies. In 2013, only 11% of states in our sample (n = 5) had Medicaid policies that excluded coverage for methadone and buprenorphine, whereas 71% (n = 32) had adopted or maintained policies to cover both buprenorphine and methadone among Medicaid enrollees. We also noted an increase in policies over the time period that may have hindered access to buprenorphine and/or methadone. CONCLUSIONS: There appears to be a trend for states to enact policies increasing Medicaid coverage of opioid agonist therapies, while in recent years also enacting policies, such as prior authorization requirements, that potentially serve as barriers to opioid agonist therapy utilization. Greater empirical information about the potential benefits and potential unintended consequences of such policies can provide policymakers and others with a more informed understanding of their policy decisions.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
7245
Policies Should Promote Access to Buprenorphine for Opioid Use Disorder
Type: Government Report
Authors: Pew Charitable Trusts
Year: 2021
Publication Place: Philadelphia, PA
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
,
Healthcare Policy See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7246
Policies to Support a Better Treatment for Heroin and Prescription Opioid Abuse: Unlike Methadone, Buprenorphine Can Be Taken at Home, but Greater Access is Key
Type: Report
Authors: Bradley D. Stein, Rosalie Liccardo Pacula, Adam J. Gordon, Andrew W. Dick, Rachel M. Burns, Douglas L. Leslie, Mark J. Sorbero, Sebastian Bauhoff, Carrie M. Farmer, Hollie Hendrikson, Todd Mandell
Year: 2015
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7248
Policy Actions To Achieve Integrated Community-Based Mental Health Services
Type: Journal Article
Authors: Mary DeSilva, Chiara Samele, Shekhar Saxena, Vikram Patel, Ara Darzi
Year: 2014
Topic(s):
Healthcare Policy See topic collection
7249
Policy challenges in building the medical home: Do we have a shared blueprint?
Type: Journal Article
Authors: R. J. Stenger, J. E. DeVoe
Year: 2010
Abstract: BACKGROUND: The notion of a patient-centered medical home features prominently in policy reform initiatives across the country, with both state and federal legislation focusing on this new model. We sought to understand the views of key stakeholders and to examine the challenging landscape facing policymakers and practitioners as they attempt to translate the medical home concept into widespread practice change. METHODS: We reviewed legislative documents from state legislative sessions in the year 2007 to identify pieces of legislation that included the medical home concept. Concurrently we conducted an in-depth qualitative analysis of de-identified field notes from a purposeful sample of semistructured interviews conducted with key stakeholders in Oregon after the passage of health reform legislation in 2007. RESULTS: Legislation that further defined and expounded on the medical home concept was introduced in states across the country in 2007, and some federal and state demonstration projects were already underway. However, we identified a number of barriers to widespread implementation of the medical home, most notably lack of a clear operational definition. Key stakeholders had widely disparate views about elements central to the success of medical home demonstrations, including delivery system reform, payment reform, and performance incentives for providers. CONCLUSIONS: Since 2007 the concept of the medical home has gained increasing attention in health care reform debates. Our findings suggest that translating this concept into successful, widespread reform will require that policymakers build further consensus among key stakeholders and require them to address critical barriers to avoid repeating pitfalls of past reform efforts.
Topic(s):
Healthcare Policy See topic collection
7250
Policy Change to Promote Early Relational Health
Type: Government Report
Authors: Center for the Study of Social Policy
Year: 2022
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7251
Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
Type: Journal Article
Authors: Rebecca L. Haffajee, Amy S. B. Bohnert, Pooja A. Lagisetty
Year: 2018
Publication Place: Netherlands
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
7252
Policy perceptions of US state public health and child and family services regarding maternal opioid use and neonatal exposure
Type: Journal Article
Authors: Lisa Fath Scott, Cynthia Stone, Joan Duwve
Year: 2019
Topic(s):
Healthcare Disparities See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
7253
Policy Priorities: Addressing the Impact of Social Isolation and Loneliness for All Americans
Type: Government Report
Authors: Coalition to End Social Isolation & Loneliness
Year: 2023
Publication Place: Washington, DC
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7255
Poly-use of cannabis and other substances among juvenile-justice involved youth: Variations in psychological and substance-related problems by typology
Type: Journal Article
Authors: Devin E. Banks, Alexandra R. Hershberger, Taylor Pemberton, Richelle L. Clifton, Matthew C. Aalsma, Tamika C. B. Zapolski
Year: 2019
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7256
Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine
Type: Journal Article
Authors: Pertti Kalevi Heikman, Leea Hellevi Muhonen, Ilkka Antero Ojanpera
Year: 2017
Publication Place: England
Abstract:

BACKGROUND: Polydrug abuse is a known problem among opioid-dependent patients receiving opioid maintenance treatment (OMT). However, improved laboratory diagnostics is required to reveal polydrug abuse in its current scope. Furthermore, there are few studies focusing on the relationship between polydrug abuse and adequacy of the dose of OMT medicine. This study aimed to evaluate the polydrug abuse among opioid-dependent patients receiving OMT with inadequate (Group IA) and adequate (Group A) doses of OMT medicine as experienced by the patients. Craving for opioids and withdrawal symptoms were evaluated as indicators of the adequacy rating. METHODS: This is a retrospective register-based study of 60 OMT patients on either methadone or sublingual buprenorphine/naloxone medication, whose polydrug abuse was studied from urine samples by means of a comprehensive high-resolution mass spectrometry method. RESULTS: Inadequate doses of the OMT medicines were associated with higher subjective withdrawal scores and craving for opioids. Six groups of abused substances (benzodiazepines, amphetamines, opioids, cannabis, new psychoactive substances, and non-prescribed psychotropic medicines) were found among OMT patients. Group IA patients showed significantly more abuse of benzodiazepines and amphetamines than the Group A patients. All the new psychoactive substances and most of the non-prescribed psychotropic medicines were detected from the Group IA patients. There was no difference in the doses of the OMT medicine between Groups IA and A patients. CONCLUSIONS: Polydrug abuse, detected by definitive laboratory methods, was widespread and more common among Group IA than Group A patients, emphasizing the requirement for individual OMT medicine dose adjustment.

Topic(s):
Opioids & Substance Use See topic collection
7258
Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine
Type: Journal Article
Authors: Jennifer Lorvick, Erica N. Browne, Barrot H. Lambdin, Megan Comfort
Year: 2018
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
7259
Polysubstance abuse associated with more frequent opioid use among patients in rural primary care settings
Type: Journal Article
Authors: D. L. Albright, J. McDaniel, K. Laha-Walsh, B. Morrison, S. McIntosh
Year: 2020
Publication Place: United States
Abstract: OBJECTIVE: Opioid use is a continuing problem for the United States. Individuals who use opioids have a high risk of misuse, especially with prescription opioids. Substances that are often used in combination with opioids include methamphetamines, sedatives, and benzodiazepines, as well as tobacco, alcohol, and marijuana, but not in a medical setting. We sought to determine (a) the relationship between various drugs (eg, methamphetamine, benzodiazepines) and opioid use, as well as (b) the relationship between polysubstance use and opioid use. DESIGN: We created a screening instrument that requested the patients seeking medical care at Federally Qualified Health Centers (FQHC) and Veterans Affairs (VA) hospitals in West Alabama self-report their substance usage. SETTING: This study took place in outpatient primary care settings (FQHCs and VA hospitals) in west Alabama. PARTICIPANTS: De-identified electronic health records for 346 adults were obtained from consenting medical facilities. Missing data were found in 33 of the records obtained. The final usable sample for this study was 311. MAIN OUTCOME MEASURE: The screening tool was comprised of five sections: demographics, tobacco use, alcohol abuse, drug use, and mental health. The primary outcome measure of this study was the number of days of opioid use in the past 30 days. RESULTS: Thirteen individuals (4.18 percent) reported opioid use in the last 30 days. While polysubstance or dual sub-stance use was not in the majority of the participant responses, the significant substances that were used in conjunction with opioids were methamphetamine, hallucinogens, and benzodiazepines. CONCLUSIONS: Individuals who are polysubstance users have a higher likelihood of opioid use. Interventions that target opioid use would serve the population stronger by including screenings and potential treatments for polysubstance use additionally.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
7260
Polysubstance Use among Patients Enrolling in Methadone Maintenance Treatment Program in a Vietnam Province with Drug-Driven HIV Epidemic
Type: Journal Article
Authors: T. A. Le, D. T. T. Pham, T. T. C. Quek, G. T. Vu, C. L. Hoang, T. T. Tran, C. T. Nguyen, N. H. T. Tran, Q. H. Vuong, T. H. Tran, B. X. Tran, C. A. Latkin, C. S. H. Ho, R. C. M. Ho
Year: 2019
Abstract:

Methadone maintenance treatment (MMT) has been scaled up significantly in recent years. This study aimed to investigate the pattern of polysubstance use in 395 MMT patients and its contextualized associated factors. A cross-sectional study was performed in three outpatient MMT clinics in Nam Dinh Province. Multivariate Poisson regression was used to identify factors associated with polysubstance use status. The mean MMT duration and the current MMT dose was 3.3 years and 69.2 mg, respectively. Among participants, 24.8% reported daily alcohol use, 68.6% smoked regularly, and 6% used illicit drugs. Peer pressure and MMT suboptimal adherence were found to associate with continual usage of drugs (47.8%). Participants who lived with a spouse/partner, were self-employed, and smoked were more likely to drink alcohol. Those who drink were also more likely to smoke, and vice versa. Recommendations for policymakers include community-based education and promotional programs aiming to decrease substance usage in the community as well as encouraging and supporting the private health sector in establishing private MMT services and clinics. Further longitudinal studies on polysubstance usage among MMT patients should also be conducted.

Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection